Kimberly-Clark Buys Tylenol at $48B
On 3 November 2025, Kimberly-Clark announced that it would acquire Kenvue, the consumer-health company behind Tylenol and other over-the-counter brands, in a cash-and-stock deal valued at approximately US$48.7 billion. Under…